Lamictal Competitor Resource Kit

LAMICTAL

ARIPIPRAZOLE

LITHIUM

OLANZAPINE

QUETIAPINE

RISPERIDONE

SSRI

TOPIRAMATE

VALPROATE

ZIPRASIDONE

OLANZAPINE

SUPPORTING DATA

Marketing information
Key claims
Reduced relapse rate
Longer time to relapse
Supporting data
At least as effective as lithium
OFC in bipolar depression
No treatment-emergent mania
Improvements in HR-Qol
Fewer drop-outs than lithium
No QTc prolongation
Usage
Country information
References

Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer


	1. Olanzapine for maintenance of bipolar disorder Authors: Tohen, et al. Title: Olanzapine’s efficacy for relapse prevention in... 2. Efficacy of olanzapine as maintenance therapy Author: Sanger, et al. Title: Long-term olanzapine therapy in the treatment of bipolar I... 3. Olanzapine vs lithium for prevention of relapse Author: Tohen, et al. Title: Olanzapine versus lithium in relapse prevention in bipolar...